Tirzepatide, used in medications like Mounjaro and Zepbound, showed even greater results, where participants in some trials lost up to 22.5% of their body weight
At Hortman Clinics, we follow rigorous, evidence-based protocols, thorough diagnostics, and ongoing monitoring to maximise benefits and minimise risks
The trial evaluated retatrutide, an investigational triple-hormone therapy targeting GIP, GLP-1 and glucagon receptors
Medicaid coverage for GLP-1s, both for Type 2 diabetes and obesity, varies widely across the United States
The mechanism is similar for both
Neuroprotection and Stroke Recovery Research Perhaps the most clinically significant research on Semax concerns its potential for neuroprotection after ischemic events